sever
acut
respiratori
syndrom
sar
first
appear
novemb
ultim
result
probabl
human
infect
death
worldwid
juli
global
outbreak
declar
new
coronaviru
sarsassoci
coronaviru
sarscov
identifi
caus
agent
viru
appear
zoonot
origin
genet
similar
coronavirus
identifi
sever
anim
speci
global
respons
outbreak
extens
within
short
period
pathogen
identifi
new
diagnost
test
develop
surveil
system
creat
infect
control
prevent
measur
institut
transmiss
among
human
stop
unclear
persontoperson
sarscov
transmiss
reappear
howev
procedur
establish
public
health
organ
includ
world
health
organ
center
diseas
control
prevent
cdc
help
guid
diagnosi
report
surveil
prevent
previous
unknown
infecti
agent
caus
widespread
global
outbreak
lifethreaten
respiratori
infect
ill
call
sever
acut
respiratori
syndrom
sar
one
first
emerg
infect
recent
histori
test
global
public
health
respons
strategi
use
prevent
control
sar
help
shape
futur
public
health
respons
infecti
diseas
emerg
influenza
pandem
sar
emerg
guangdong
provinc
china
midnovemb
first
offici
report
februari
midmarch
issu
alert
call
attent
sever
outbreak
sever
atyp
pneumonia
hong
kong
hanoi
singapor
mani
initi
sar
infect
trace
guest
stay
hong
kong
hotel
global
spread
occur
quickli
multipl
outbreak
report
china
southeast
asia
europ
north
america
midapril
caus
agent
identifi
new
coronaviru
sarscov
unpreced
global
outbreak
respons
includ
implement
surveil
system
epidemiolog
studi
appropri
infect
control
measur
develop
laboratori
diagnost
swiftli
initi
juli
announc
sar
outbreak
although
laboratoryassoci
sar
infect
report
asia
outbreak
declar
infect
report
worldwid
sinc
earli
almost
person
sar
report
china
hong
kong
taiwan
singapor
toronto
overal
decemb
receiv
report
sar
countri
region
person
probabl
sar
result
death
casefat
rate
unit
state
eight
infect
document
laboratori
test
addit
probabl
infect
report
syndrom
aros
vanish
within
sever
month
unclear
sar
return
coronavirus
envelop
singlestrand
posit
strand
ribonucl
acid
rna
virus
infect
wide
spectrum
mammal
bird
three
coronaviru
group
group
ii
affect
mammal
group
iii
affect
bird
human
coronavirus
primarili
associ
upper
respiratori
infect
sar
outbreak
sever
strain
coronaviru
unrel
previous
describ
coronavirus
identifi
isol
clinic
sampl
includ
respiratori
secret
urin
autopsi
tissu
new
viru
identifi
novel
group
ii
coronaviru
name
sarsassoci
coronaviru
coronavirus
respons
caus
sever
human
diseas
bat
identifi
natur
reservoir
sarscovlik
virus
like
natur
reservoir
sarscov
therefor
sar
zoonosi
studi
anim
ecolog
viru
evolut
reveal
sarscovlik
virus
also
present
anim
includ
commonli
trade
live
anim
market
southern
china
eg
mask
palm
civet
raccoon
dog
red
fox
time
unclear
anim
suscept
host
carrier
sarscov
recent
research
indic
mask
palm
civet
probabl
serv
intermedi
host
bat
human
outbreak
sequenc
analys
sarscov
shown
sarscovlik
virus
infect
mask
palm
civet
similar
genom
ident
sarscov
infect
human
sar
outbreak
suggest
viru
recent
circul
mask
palm
civet
increas
preval
sarscov
immunoglobulin
g
igg
antibodi
among
anim
trader
compar
control
group
versu
support
theori
addit
absenc
sarscov
antibodi
gener
popul
without
clinic
evid
sar
suggest
sarscov
wide
circul
sar
outbreak
estim
incub
period
sar
day
median
day
viru
detect
low
level
occur
via
aerosol
patient
procedur
intub
bronchoscopi
transmiss
also
document
airplan
apart
complex
probabl
secondari
faulti
plumb
aerosol
fecal
matter
among
laboratori
worker
handl
sarscov
transmiss
viru
report
via
foodborn
waterborn
sourc
infect
patient
whose
fever
resolv
day
previous
seen
infecti
diseas
environment
host
factor
influenc
risk
transmiss
although
viru
initi
thought
highli
infecti
rate
secondari
transmiss
sarscov
estim
low
moder
transmiss
model
studi
estim
patient
infect
averag
three
person
howev
sarsinfect
patient
design
superspread
document
high
secondari
transmiss
rate
infect
averag
contact
rang
contact
phenomenon
uniqu
sar
transmiss
sarscov
superspread
primarili
occur
hospit
set
associ
greater
number
close
contact
delay
diagnosi
older
age
sever
ill
poor
infect
control
practic
sever
diseas
among
sar
patient
vari
asymptomat
infect
fatal
acut
respiratori
distress
syndrom
ard
figur
seropreval
survey
document
asymptomat
infect
especi
among
anim
trader
guangdong
china
overal
asymptomat
mild
diseas
rel
uncommon
sar
affect
person
age
howev
infect
occur
among
adult
median
age
approxim
year
infect
among
children
especi
younger
year
age
uncommon
compar
adult
diseas
consider
less
sever
among
children
outcom
much
favor
infect
pregnanc
document
increas
risk
spontan
abort
preterm
labor
sever
pulmonari
diseas
death
report
perinat
transmiss
note
respiratori
secret
initi
day
onset
ill
peak
viral
level
occur
second
week
ill
eg
day
viral
replic
phase
follow
immun
hyperreact
phase
occur
diseas
sever
increas
viral
load
decreas
diseas
progress
variabl
patient
progress
final
pulmonari
destruct
phase
primari
rout
sarscov
transmiss
via
respiratori
tract
close
contact
infect
patient
respiratori
droplet
may
come
contact
mucou
membran
either
directli
indirectli
contamin
fomit
studi
determin
sarscov
remain
stabl
environment
surfac
sever
day
although
viru
easili
inactiv
disinfect
viru
isol
respiratori
secret
saliva
tear
urin
stool
viral
shed
gener
persist
beyond
week
except
stool
viru
detect
revers
transcriptionpolymeras
chain
reaction
rtpcr
longer
month
isol
viru
month
onset
ill
rare
viru
detect
nasopharyng
specimen
use
quantit
rtpcr
found
level
typic
peak
second
week
ill
often
sever
ill
patient
seek
medic
care
patient
improv
clinic
viral
load
decreas
transmiss
viru
also
decreas
unlik
respiratori
viral
infect
influenza
transmiss
symptom
onset
report
recent
sar
outbreak
transmiss
occur
primarili
hospit
less
within
household
even
lesser
extent
within
commun
outbreak
primari
risk
factor
contact
person
infect
sarscov
twentyon
percent
report
sarscov
infect
occur
among
healthcar
worker
nosocomi
transmiss
sarscov
common
earli
outbreak
subsequ
decreas
significantli
result
earli
diagnosi
reinforc
infect
control
practic
nosocomi
spread
theoriz
ard
occur
lung
infect
injur
typic
fluid
fill
air
sac
lung
oxygen
ca
nt
get
bodi
lung
heart
initi
chest
radiograph
find
may
unremark
indistinguish
caus
infecti
pneumonia
patient
howev
serial
chest
radiograph
highresolut
comput
tomographi
ct
scan
may
offer
valuabl
inform
evalu
patient
suspect
sar
abnorm
appear
larg
proport
patient
day
ill
typic
chest
radiograph
ground
glass
appear
focal
opac
consolid
peripher
lower
lung
field
focal
find
often
progress
bilater
patchi
consolid
figur
peripher
lung
involv
common
find
case
studi
outbreak
pulmonari
cavit
hilar
lymphadenopathi
nodular
infiltr
pleural
effus
unusu
figur
evid
extrapulmonari
dissemin
sarscov
found
laboratori
patholog
diagnost
method
viru
detect
sever
extrapulmonari
organ
includ
gastrointestin
tract
kidney
liver
spleen
studi
improv
understand
sar
pathogenesi
immun
respons
ongo
common
laboratori
find
patient
sar
includ
moder
lymphocytopenia
low
normal
white
blood
cell
count
primarili
caus
decreas
tcell
lineag
mild
thrombocytopenia
increas
serum
lactat
dehydrogenas
ie
three
five
time
upper
limit
normal
elev
serum
hepat
transaminas
decreas
tcell
count
signific
infect
patient
tcell
count
cellsmm
elev
serum
creatinin
phosphokinas
noncardiac
electrolyt
initi
symptom
sar
nonspecif
consist
influenzalik
ill
prodrom
includ
fever
headach
chill
rigor
malais
myalgia
occur
approxim
day
exposur
figur
nearli
patient
report
fever
temperatur
frequent
exceed
f
typic
preced
prodrom
symptom
also
occur
prodrom
elderli
histori
chronic
comorbid
condit
diabet
mellitu
chronic
renal
failur
may
atyp
present
eg
lack
fever
although
sar
primarili
affect
pulmonari
system
respiratori
symptom
typic
includ
nonproduct
cough
short
breath
appear
often
second
week
ill
one
report
patient
seri
gastrointestin
symptom
primarili
diarrhea
promin
highvolum
diarrhea
occur
second
week
ill
separ
report
diarrhea
nausea
vomit
less
common
mucu
blood
stool
uncommon
diarrhea
often
selflimit
lymphadenopathi
rhinorrhea
sore
throat
rash
purpura
unusu
person
sar
inspiratori
crackl
lung
base
less
commonli
wheez
may
note
auscultatori
examin
initi
consist
find
pauciti
auscultatori
find
rel
degre
abnorm
display
chest
radiograph
second
week
ill
clinic
deterior
may
occur
pneumonia
hypoxemia
necessit
hospit
outbreak
respiratori
failur
ard
common
reason
admiss
intens
care
unit
icu
sever
studi
approxim
patient
hospit
sar
admit
icu
icu
patient
requir
mechan
ventil
chest
radiograph
provid
valuabl
inform
typic
earli
find
includ
ground
glass
appear
focal
opac
consolid
peripher
lower
lung
field
often
progress
bilater
patchi
consolid
earli
sar
symptom
similar
respiratori
infect
includ
headach
chill
myalgia
fever
typic
seen
first
week
follow
onset
follow
cough
short
breath
typic
appear
second
week
diagnost
method
viru
isol
electron
microscopi
immunohistolog
also
avail
routin
use
specif
technolog
requir
safeti
issu
eg
viru
isol
requir
biosafeti
level
laboratori
viru
caus
sar
detect
number
clinic
specimen
includ
respiratori
fluid
tissu
ie
nasopharyng
oropharyng
npop
swab
nasal
aspir
sputum
bronchoalveolar
lavag
bal
specimen
lung
tissu
serum
stool
urin
hepat
tissu
optim
laboratori
diagnosi
type
specimen
obtain
time
specimen
collect
rel
ill
onset
import
sar
outbreak
rapid
detect
sar
initi
hamper
sever
factor
diagnost
assay
develop
highlevel
biosafeti
requir
work
live
viru
low
viral
load
clinic
specimen
time
requir
host
mount
antibodi
limit
sensit
assay
detect
earli
sarscov
infect
outbreak
studi
firstgener
quantit
rtpcr
assay
detect
viru
level
respiratori
specimen
found
sarscov
rna
detect
less
abnorm
includ
hypocalcemia
hypokalemia
hypomagnesemia
hypophosphatemia
also
commonli
seen
sar
import
note
sinc
worldwid
absenc
humantohuman
transmiss
sarscov
result
resourc
laboratori
diagnosi
sar
infect
limit
test
reserv
situat
high
level
suspicion
exist
possibl
sarscov
infect
unit
state
cdc
develop
guidelin
clinic
public
health
manag
sar
includ
specif
criteria
algorithm
laboratori
test
see
section
prevent
control
detail
explan
respons
sar
outbreak
laboratori
diagnost
rapidli
develop
detect
newli
identifi
coronaviru
method
choic
current
includ
detect
sarscovspecif
antibodi
serum
use
enzym
immunoassay
eia
immunofluoresc
assay
ifa
detect
sarscov
rna
clinic
specimen
use
realtim
rtpcr
approxim
patient
sar
clinic
improv
within
week
two
onset
ill
wherea
develop
persist
fever
worsen
respiratori
symptom
may
requir
hospit
admit
icu
length
hospit
stay
vari
sever
studi
report
median
length
stay
approxim
week
hospit
patient
common
complic
sar
includ
cardiovascular
abnorm
eg
hypotens
tachycardia
hepat
dysfunct
deep
vein
thrombosi
dvt
less
common
one
singapor
case
seri
hospit
patient
evid
dvt
dissemin
intravascular
coagul
acut
renal
failur
neurolog
complic
uncommon
sar
outbreak
poor
outcom
associ
increas
age
presenc
comorbid
condit
eg
diabet
mellitu
hypertens
cardiovascular
diseas
chronic
renal
diseas
overal
crude
mortal
rate
rang
agespecif
mortal
rate
highest
among
older
adult
mortal
rate
higher
age
year
older
compar
younger
year
age
sar
patient
surviv
complet
sometim
prolong
recoveri
sever
ill
patient
report
longterm
decreas
pulmonari
function
unclear
world
experi
anoth
sar
epidem
absenc
persontoperson
sarscov
transmiss
worldwid
recommend
publish
sever
public
health
organ
includ
cdc
unit
state
cdc
develop
sever
document
provid
guidanc
surveil
clinic
laboratori
evalu
report
suspect
sar
infect
wwwcdcgovncidodsar
familiar
clinic
featur
sarscov
diseas
assess
travel
histori
exposur
risk
recogn
unusu
cluster
unexplain
pneumonia
help
maxim
earli
detect
absenc
persontoperson
transmiss
public
health
healthcar
personnel
awar
specif
set
rais
suspicion
sarscov
infect
wwwcdcgovncidodsar
absenceofsarshtm
situat
includ
person
hospit
radiograph
confirm
pneumonia
ard
without
identifi
caus
one
follow
three
risk
factor
day
onset
ill
specimen
obtain
first
day
ill
viral
load
peak
day
gradual
declin
addit
studi
confirm
day
rna
detect
rtpcr
major
respiratori
stool
specimen
second
gener
rtpcr
assay
develop
outbreak
end
detect
sarscov
rna
respiratori
specimen
within
first
day
symptom
onset
upper
respiratori
tract
specimen
neg
sputum
bal
specimen
may
use
diagnosi
viral
load
may
greater
lower
respiratori
tract
stool
rtpcr
assay
abl
detect
sarscov
rna
week
ill
onset
howev
viru
isol
stool
third
week
serolog
test
use
tool
diagnosi
permit
detect
antisar
antibodi
well
help
confirm
exclud
sar
diagnosi
better
character
sar
immun
respons
host
immun
respons
includ
develop
igg
igm
sarscovspecif
antibodi
well
antisarscov
neutral
antibodi
longitudin
studi
conduct
outbreak
use
ifa
eia
specimen
obtain
outbreakrel
sar
patient
show
first
day
ill
detect
antisarscov
igg
igm
howev
second
week
ill
igg
detect
approxim
patient
igm
patient
detect
antisarscov
igg
day
ill
onset
mileston
import
undetect
antisar
antibodi
serum
specimen
obtain
day
onset
ill
one
three
exclus
criteria
recommend
cdc
defin
infect
probabl
sar
case
studi
follow
progress
antibodi
titer
patient
sar
found
level
antisarscov
igg
peak
month
onset
ill
decreas
year
infect
igg
still
detect
patient
secondgener
immunoassay
develop
focus
recombin
sarscov
nucleoprotein
antigen
howev
crossreact
antigen
epitop
sarscov
human
coronavirus
newli
discov
also
caus
respiratori
ill
may
complic
serolog
test
result
merit
continu
investig
diagnosi
sar
base
singl
reactiv
laboratori
test
reactiv
result
confirm
laboratori
particip
sar
intern
refer
verif
laboratori
network
appar
lack
circul
sarscov
human
singl
reactiv
serolog
test
may
support
diagnosi
posit
predict
valu
serolog
test
low
confirm
experienc
laboratori
still
recommend
test
result
suggest
diagnosi
sar
must
evalu
context
clinic
find
exposur
risk
factor
epidemiolog
data
posit
predict
valu
laboratori
diagnosi
increas
collect
test
multipl
differ
specimen
type
clinic
manag
sar
primarili
reli
provid
support
care
acut
respiratori
ill
test
made
guidelin
laboratori
personnel
work
sarscov
avail
wwwcdcgovncidodsar
global
sar
one
select
condit
design
immedi
report
intern
health
regul
local
state
health
depart
promptli
notifi
suspect
sar
case
identifi
prompt
case
detect
implement
infect
control
measur
includ
patient
isol
standard
droplet
precaut
wwwcdcgovncidodsarsguidanceipdfipdf
contact
trace
shown
reduc
transmiss
addit
infect
control
measur
institut
depend
set
eg
healthcar
home
commun
wwwcdcgov
ncidodsarsguidanceipdfipdf
one
critic
lesson
learn
sar
outbreak
appar
need
prompt
collabor
open
commun
among
local
nation
intern
health
agenc
earli
diagnosi
time
report
implement
infect
control
measur
continu
research
includ
research
regard
treatment
vaccin
develop
help
identifi
control
possibl
futur
sar
outbreak
travel
mainland
china
hong
kong
taiwan
close
contact
ill
person
histori
recent
travel
one
area
employ
occup
associ
risk
sarscov
exposur
eg
healthcar
worker
worker
laboratori
contain
sarscov
ill
associ
cluster
case
atyp
pneumonia
without
altern
diagnosi
clinician
evalu
patient
fit
one
three
criteria
implement
appropri
infect
control
measur
contact
local
state
health
depart
continu
diagnost
evalu
evalu
includ
test
respiratori
pathogen
eg
influenza
respiratori
syncyti
viru
streptococcu
pneumonia
legionella
speci
altern
diagnosi
made
hour
high
index
suspicion
sar
exist
clinician
health
depart
consid
sarscov
test
contact
cdc
consult
current
laboratoryacquir
sar
infect
remain
possibl
scenario
remot
one
adher
strict
biosafeti
laboratori
polici
significantli
reduc
risk
cdc
avail
consult
